Metrion Biosciences and LifeArc Extend Ion Channel Drug Discovery Collaboration to Accelerate Neuroscience-focused Research

CAMBRIDGE, England & LONDON--(BUSINESS WIRE)--Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and LifeArc, a leading UK independent medical research charity, today announced an extension of their neuroscience-focused ion channel drug discovery collaboration, following the success of the initial twelve-month agreement. The collaboration is focused on novel selective small molecular modulators of a specific two-pore domain potassium ion channel ta

Full Story →